AH.6809, fasudil, W.13, and X4.5dianilimophthalimide exhibited notably lower scores in most cancer types, suggesting their potential to inhibit DKC1-mediated oncogenic effects (Fig. 9D). This evidence concerns the gene DKC1 and cancer.